Clinical trials recruiting in Scottdale, Pennsylvania
8
Recruiting trials
11
Conditions
Phase breakdown
Phase 2 2Phase 3 6
Conditions recruiting in Scottdale, Pennsylvania
Recruiting trials in Scottdale, Pennsylvania
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Common questions
How many clinical trials are recruiting in Scottdale, Pennsylvania?
8 recruiting trials have at least one study site in Scottdale, Pennsylvania.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.